COMMUNIQUÉS West-GlobeNewswire

FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
30/04/2026
Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertension despite medication at [...]
Vicarious Surgical Reports First Quarter 2026 Financial Results
30/04/2026
WALTHAM, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming [...]
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
30/04/2026
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight ® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision [...]
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
30/04/2026
Data demonstrate progress in each of its MSC-derived programs MELVILLE, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative," "BRTX," or the "Company") (Nasdaq: BRTX), a late-stage [...]
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
30/04/2026
Grants OPKO a 15% equity interest in Nicoya MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced that its subsidiary EirGen Pharma Limited (EirGen) has entered into an [...]
Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT)
30/04/2026
RICHMOND, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted three [...]
New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms
30/04/2026
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized [...]
Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations
30/04/2026
DENVER, April 30, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com )- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or the “Company”), a leading developer of recombinant spider silk-based fibers, has achieved [...]
TimelyCare Expands Its Basic Needs Service to Help Colleges Better Support Student Retention
30/04/2026
Expanded offerings introduce Basic Needs Navigate and Basic Needs Connect, giving colleges and universities more flexible ways to deliver coordinated support at scale Fort Worth, TX, April 30, 2026 (GLOBE NEWSWIRE) -- [...]
Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
30/04/2026
Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced environmental impact. Through its global access to medicines programs, Teva reached [...]
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
30/04/2026
Commencement of activities in international markets is supported by the successful completion of the Limited Market Release, followed by the Recent Full Market Release in the U.S. Strong physician interest at recent [...]
Centre for Neuro Skills CEO David Harrington Joins Brain to Brain Podcast to Discuss the Science of Recovery, Advocacy for Brain Injury Care and Why It Is Never Too Late
30/04/2026
Brain injury rehabilitation leader shares his personal story, CNS’s recovery-focused philosophy and the real barriers patients face in accessing the care they need BAKERSFIELD, Calif., April 30, 2026 (GLOBE NEWSWIRE [...]
Precision Neuroscience™ Partners With UChicago Medicine Researchers to Advance Brain–Computer Interface Research
30/04/2026
The collaboration expands Precision's clinical research network, deepening investigation into AI-driven neural cursor control and neuroprosthetics NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience [...]
VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery
30/04/2026
Prospective Study Conducted at Holy Spirit Hospital in Mumbai Reports 95% Vein Occlusion Rate at 30 VANCOUVER, BC, April 30, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a developer [...]
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer
30/04/2026
, April 30, 2026 (GLOBE NEWSWIRE) -- EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate Cancer AUSTIN, Texas, April 30, 2026 - EDAP TMS SA ( [...]
TOMI Environmental Solutions Signs Letter of Intent for a Merger with Carbonium Core, Inc., a U.S.-Based Producer of Nuclear-Grade Graphite for Advanced Reactors and Infrastructure Demands of AI Data Centers
30/04/2026
Establishes domestic platform in advanced graphite, addressing a multi-billion-dollar end market underpinned by U.S. supply-chain reshoring and next-generation nuclear and AI data center demands FREDERICK, Md., April 30 [...]
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
30/04/2026
ASHBURN, Va., April 30, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
30/04/2026
CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced [...]
Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors
30/04/2026
Nelson Joins as the Company Builds the Leadership Infrastructure for Its Next Phase SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence [...]

Pages